BIPOLAR II DISORDER
Clinical trials for BIPOLAR II DISORDER explained in plain language.
Never miss a new study
Get alerted when new BIPOLAR II DISORDER trials appear
Sign up with your email to follow new studies for BIPOLAR II DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ketamine infusions help sustain mood gains in tough-to-treat bipolar depression
Disease control CompletedThis study looked at whether repeated ketamine infusions could keep depression symptoms away in people with bipolar disorder who had already responded to an initial course of ketamine. Forty-one adults who completed a prior ketamine trial received up to six additional infusions o…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Disease control
Last updated May 06, 2026 16:00 UTC
-
New pill aims to calm agitation at home for schizophrenia and bipolar patients
Symptom relief CompletedThis study tested an investigational medication called BXCL501 for calming agitation episodes in people with bipolar disorder, schizophrenia, or related conditions. 452 adults took either the drug or a placebo, and researchers measured changes in agitation levels and safety. The …
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE3 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated May 06, 2026 16:03 UTC
-
New pill aims to lift bipolar depression in 6 weeks
Symptom relief CompletedThis study tested an experimental drug called ABBV-932 in 161 adults with bipolar I or II disorder who were currently experiencing a depressive episode. Participants took either the drug or a placebo daily for 6 weeks. The goal was to see if the drug safely reduces depression sym…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated May 01, 2026 15:58 UTC